Enochian Biosciences, Inc.
ENOB · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $429 | $250 | $32 | $101 |
| - Cash | $0 | $0 | $1,874,480 | $9 |
| + Debt | $10 | $4 | $5,593,956 | $7 |
| Enterprise Value | $439 | $254 | $3,719,508 | $99 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$177 | -$82 | -$40,150,904 | -$113,682,680 |
| % Margin | – | – | – | – |
| Net Income | -$178 | -$81 | -$39,684,056 | -$113 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.08 | -0.84 | -705,301.71 | -2.16 |
| % Growth | -28.6% | 100% | -32,652,756.9% | – |
| Operating Cash Flow | -$8 | -$11 | -$11,774,549 | -$16 |
| Capital Expenditures | $0 | -$0 | -$29,774 | -$0 |
| Free Cash Flow | -$8 | -$11 | -$11,804,323 | -$16 |